recent immunotherapy advances in hcc management
Published 1 year ago • 1.4K plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
3:10
advancements in immunotherapy for hepatocellular carcinoma
-
1:13
choosing the best treatment regimen in advanced hepatocellular carcinoma
-
1:21
unmet needs in immunotherapy for hepatocellular carcinoma
-
1:10
the impact of immunotherapy and checkpoint inhibition in treating hcc
-
3:29
aacr 2023 highlights on advances in the treatment of hepatocellular carcinoma with pierce chow
-
11:28
tgf-β signaling pathway disruption for effective treatment of hcc with nk cells
-
48:02
transforming care and outcomes with immunotherapy in stage i-iii resectable nsclc
-
1:25:17
cri’s 7th annual patient immunotherapy summit - december 2023 full cut
-
0:41
keystep-004: combination immunotherapy with lenvatinib for advanced hcc
-
1:56
improving outcomes in hcc with immunotherapy
-
1:34
immunotherapy & local ablative therapy in mcrc with liver metastases
-
1:16
assessing treatment options for hepatocellular carcinoma
-
2:25
keynote-224: second-line pembrolizumab for advanced hepatocellular carcinoma
-
2:09
keynote-240: pembrolizumab in advanced hcc
-
1:23
improving upon immunotherapy advances in hcc
-
50:13
advanced treatments in liver cancer
-
2:43
new immunotherapies bring hope to patients with rare liver cancers
-
3:56
novel developments in hcc treatment
-
1:27
takeaways in hepatocellular carcinoma at asco gi 2023
-
24:30
reviewing the outcomes in hcc with 1st line immunotherapy: when is the right time to switch?
-
3:17
new treatment options for those with liver cancer
-
3:55
the use of immunotherapy in hcc – efficacy and safety